Rocket


Overview
Financials
News + Filings
Key Docs
Insiders

 
 

Fusion Pharmaceuticals Inc. (FUSN) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17
Revenues10.66.9 
            Revenue growth54.5%  
Cost of goods sold18.210.1 
Gross profit-7.6-3.2 
            Gross margin-71.4%-46.8% 
General and administrative7.63.2 
EBIT-18.2-10.1 
            EBIT margin-171.4%-146.8% 
Pre-tax income-15.9-11.5 
Income taxes0.30.2 
Net income0.00.0 
            Net margin-0.2%-0.2% 
 
Diluted EPS($8.45)($6.22) 
Shares outstanding (diluted)0.00.0 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy